scholarly journals Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia

2005 ◽  
Vol 28 (9) ◽  
pp. 423-428 ◽  
Author(s):  
Hsin-Bang Leu ◽  
Jaw-Wen Chen ◽  
Tao-Cheng Wu ◽  
Yu-An Ding ◽  
Shing-Jong Lin ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Reductase Inhibitor ◽  
Serum Levels ◽  
Matrix Metalloproteinase 9 ◽  
Interleukin 18 ◽  
Hmg Coa Reductase ◽  
Hmg Coa Reductase Inhibitor ◽  
Coa Reductase ◽  
Metalloproteinase 9

Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells

2004 ◽  
Author(s):  
Takemi Otsuki ◽  
Haruko Sakaguchi ◽  
Tamayo Hatayama ◽  
Tomohiro Fujii ◽  
Takayuki Tsujioka ◽  
...  
Keyword(s):  
Reductase Inhibitor ◽  
Hmg Coa Reductase ◽  
Myeloma Cells ◽  
Hmg Coa Reductase Inhibitor ◽  
Coa Reductase ◽  
Human Myeloma Cells

Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin

1989 ◽  
Vol 3 (2) ◽  
pp. 219-227 ◽  
Author(s):  
GMB Berger ◽  
AD Marais ◽  
HC Seftel ◽  
SG Baker ◽  
D Mendelsohn ◽  
...  
Keyword(s):  
Reductase Inhibitor ◽  
Hmg Coa Reductase ◽  
Hmg Coa Reductase Inhibitor ◽  
Coa Reductase
Sign in / Sign up

Export Citation Format

Share Document